American Hospital Dubai has partnered with global healthcare company Abbott to advance early cancer detection in the UAE, with the collaboration set to introduce next-generation diagnostic technology to the country’s healthcare sector.
The two organisations have signed a Memorandum of Understanding (MoU) aimed at expanding access to advanced cancer detection solutions. American Hospital Dubai will be the first private healthcare provider in Dubai to introduce the new early-stage detection technology.
The partnership comes as the UAE continues to strengthen its healthcare infrastructure and focus on earlier diagnosis as part of efforts to improve cancer treatment and reduce mortality.
Early detection can play an important role in cancer care by allowing patients and medical teams to identify the disease sooner and begin appropriate treatment at an earlier stage. The new technology is expected to support the UAE’s wider efforts to improve diagnostic capabilities and cancer-care outcomes.
Sherif Beshara, Group CEO of American Hospital Dubai, said the agreement represents an important step in advancing cancer diagnostics in the country.
“We are extremely pleased to partner with Abbott to usher in a new chapter for cancer diagnostics in the UAE,” Beshara said, highlighting the importance of early detection in improving cancer-care outcomes.
American Hospital Dubai has built its reputation around patient-focused care, advanced diagnostics and evidence-based treatment. Abbott operates across several healthcare fields, including diagnostics, medical devices, nutrition and medicines.
The agreement brings together the healthcare provider’s clinical expertise and Abbott’s global experience in medical technology, with the aim of making advanced diagnostic solutions available to patients in the UAE.
The initiative is also aligned with national healthcare priorities focused on strengthening cancer prevention, diagnosis and treatment. By supporting earlier detection, the partnership could contribute to the country’s long-term efforts to improve cancer outcomes and enhance the quality of care available to patients.
